This chemicals company signs a MoU with 3xper Innoventure Ltd, a technological collaboration for new age pharma molecules!
This chemicals company signs a MoU with 3xper Innoventure Ltd, a technological collaboration for new age pharma molecules!

This chemicals company signs a MoU with 3xper Innoventure Ltd, a technological collaboration for new age pharma molecules!

The company has delivered returns of 63 per cent over the past year and returns of 102 per cent from the date of its listing in March 2021.

DSIJ Intelligence Article rating: 4.0

A leading Indian company specializing in custom synthesis (CSM) and the manufacturing of specialty chemicals.

DSIJ MINDSHARE

Mindshare31-May, 2025

Quarterly Results1-Jun, 2025

Dividend1-Jun, 2025

Swing Trading1-Jun, 2025

Multibaggers1-Jun, 2025

Knowledge

Knowledge30-May, 2025

MF15-May, 2025

MF2-May, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR